Denosumab-bnht
Generic Name: denosumab-bnht
Dosage form: INJECTION. Active ingredients: DENOSUMAB (120 mg/1.7mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION. Active ingredients: DENOSUMAB (120 mg/1.7mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection.
Related Medications
Atovaquone And Proguanil Hydrochloride Pediatric
atovaquone and proguanil hydrochloride pediatric
Antimalarial [EPC]
11 DESCRIPTION Atovaquone and proguanil hydrochloride tablets (adult strength) and Atovaquone and proguanil hydrochloride pediatric tablets, for oral administration, contain a fixed-dose combination of the antimalarial agents atovaquone, USP and proguanil hydrochloride, USP. The chemical name of atovaquone, USP is trans -2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione.
Aod 9604 Acetate
aod 9604 acetate
Dosage form: POWDER. Active ingredients: LAT-8881 (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Iopromide
iopromide
Radiographic Contrast Agent [EPC]
11 DESCRIPTION ULTRAVIST (iopromide) injection is a nonionic radiographic contrast agent for intra-arterial or intravenous administration. The chemical name for iopromide is N,N' -Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]- N -methyl- 1,3- benzenedicarboxamide. Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.